Skip to main content

Table 1 Results of immunological evaluation*

From: X-linked agammaglobulinemia diagnosed late in life: case report and review of the literature

 

Patient 1

Patient 2

Age

64

46

WBC (cells/uL)

8.3 (3.2–9.8)

6.9 (5.0–10.2)

Granulocytes (%)

59 (42–75)

68 (45–75)

Lymphocytes (%)

28 (20–51)

18 (20–50)

Monocytes (%)

9.5 (0–12)

12 (0–8)

IgM (mg/dL)

25

95 (50–300)

IgG (mg/dL)

360

260 (565–1765)

IgA (mg/dL)

27

16 (40–350)

C3 (mg/dL)

ND

129 (85–200)

C4 (mg/dL)

ND

23 (14–53)

CH50 (U/ml)

ND

51 (22–60)

CD4+ (cells/uL)

1023 (720–1440)

624 (575–1070)

CD8+ (cells/uL)

979 (315–788)

477 (190–860)

NK (cells/uL)

ND

135 (150–880)

CD19+ (cells/uL)

0 (113–495)

0 (70–300)

SPEP

Hypogammaglobulinemia

Hypogammaglobulinemia

Pneumococcal responses

Impaired

Impaired

  1. Abbreviations: SPEP, serum protein electrophoresis; WBC, white blood cells; NK, natural killer;
  2. * Values in parentheses represent reference ranges